2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin

CAS: 69567-11-9

Ref. 3D-MT146309

Produktinformation

• Name: 2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin
• Synonyme: 2,3,4,6-Tetra-O-benzyl-1,5-dideoxy-1,5-imino-D-glucitol, Piperidine,3,4,5-tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, [2R-(2a,3b,4a,5b)]-, Deoxynojirimycin tetrabenzylether

Beschreibung

2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin is a synthetic atypical carbohydrate that has been shown to have anti-hyperglycemic and anti-hyperlipidemic effects. It is a benzylated derivative of the natural product 1-deoxynojirimycin. This compound has been shown to be effective in treating metabolic disorders such as polycystic ovary syndrome and hypercholesterolemia. 2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin may act by mimicking the actions of insulin and binding to insulin receptors on cells. This binding prevents the insulin receptor from being phosphorylated by an enzyme called protein kinase A (PKA), thereby inhibiting the action of PKA.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 523.66 g/mol
• Formel: C₃₄H₃₇NO₄
• Reinheit: Min. 95%